Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Mycoses 1Leukemia, Biphenotypic, Acute 1Diarrhea 1Bacterial Infections 1

Interventions

Methotrexate 11Cyclophosphamide 11Cytarabine 10merphos 8Vincristine 8Asparaginase 8Specimen Handling 7Daunorubicin 7Methylprednisolone 6Mercaptopurine 6Hydrocortisone 6pegaspargase 5fludarabine phosphate 5calaspargase pegol 5Prednisone 5Leucovorin 5Dexamethasone 5Biopsy 5fludarabine 4dexamethasone acetate 4dexamethasone 21-phosphate 4azathiopurine 4auricularum 4Whole-Body Irradiation 4Thioguanine 4Prednisolone 4Mycophenolic Acid 4Filgrastim 4Doxorubicin 4Calcium Dobesilate 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Biphenotypic, Acute × Levofloxacin × Clear all
NCT01371656 2020-12-07

Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation

Children's Oncology Group

Phase 3 Completed
624 enrolled 16 charts
LymphoidOther hematologic neoplasm

Bacterial Infections, Diarrhea, Mycoses, Neutropenia, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡